Favourable safety profile for apricitabine in HIV-1 infections.
In: Anti-Infectives Today, 2008-09-06, Heft 117, S. 5-5
serialPeriodical
Zugriff:
The article reports on a study presented at the 17th International AIDS Conference showing a combination of apricitabine and other antiretroviral therapy (ART) is safe and well tolerated in patients with human immunodeficiency virus (HIV)-1 infection. Patients involved in the study had the M184V mutation and treatment. The most common ARTs used together with apricitabine include didanosine, abacavir and tenofovir. Adverse events (AEs) of the treatment were said to be gastrointestinal.
Titel: |
Favourable safety profile for apricitabine in HIV-1 infections.
|
---|---|
Zeitschrift: | Anti-Infectives Today, 2008-09-06, Heft 117, S. 5-5 |
Veröffentlichung: | 2008 |
Medientyp: | serialPeriodical |
ISSN: | 1174-5924 (print) |
Schlagwort: |
|
Sonstiges: |
|